Coromandal Biotech Industries (India) Limited - Company Profile

It is a agriculture public limited company based in Andhra Pradesh, Andhra Pradesh, India, established in 1992.
1992 Andhra Pradesh, Andhra Pradesh, India Active
Last Updated:
About Coromandal Biotech Industries (India) Limited

Coromandal Biotech Industries (India) Limited, a active public limited company, was established on 12 March 1992 in Andhra Pradesh, Andhra Pradesh, India. Engaging in fisheries & aquaculture within the agriculture sector, it holds CIN: U05005AP1992PLC013968. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹8.57 Cr.

It upholds a compliant status. Its leadership includes Menakuru Seetharamireddy (Director), Duvvuru Suman Reddy (Director), Venkatanarasa Reddy Naidu (Managing Director). Past directors included Menakuru Seetharamireddy, Koduru Siva Kumar Reddy, Mosali Konda Reddy. It holds no open charges and ₹2.60 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sy No. 962Kothakodur (V) T P Gudur (M), Andhra Pradesh, Andhra Pradesh.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U05005AP1992PLC013968

  • Registration Number

    013968

  • Incorporation Date

    12 March 1992

  • Authorized Capital

    ₹15.00 Cr

  • Paid-Up Capital

    ₹8.57 Cr

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 15.00 Cr
  • Paid Up Capital ₹ 8.57 Cr
  • Company Age 33 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 2.60 Cr
  • Revenue Growth **** 56.24%
  • Profit Growth **** 48.37%
  • Ebitda **** -68.59%
  • Net Worth 5.87%
  • Total Assets **** 3.20%
Company report

Coromandal Biotech Industries (India) Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Coromandal Biotech Industries (India) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Coromandal Biotech Industries (India) Limited?
Current Directors
Name Designation Appointment Date Status
Menakuru Seetharamireddy Director 13 Feb 2019 Current
Duvvuru Suman Reddy Director 09 Aug 2025 Current
Venkatanarasa Reddy Naidu Managing Director 17 Oct 1994 Current
Devireddy Venkata Krishna Reddy Director 29 Sep 2017 Current
Kaku Mahesh Reddy Director 09 Aug 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Director 05 Dec 2012 Past
Pramod Abcsdd Additional Director 29 Sep 2025 Past
Pramod Abcsdd Director 08 Aug 2025 Past
Pramod Abcsdd Director 26 Mar 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Coromandal Biotech Industries (India).

Coromandal Biotech Industries (India) Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 56.24% increase. The company also saw a substantial improvement in profitability, with a 48.37% increase in profit. The company's net worth moved up by a moderate rise of 5.87%.

Coromandal Biotech Industries (India) revenue growth over time
Coromandal Biotech Industries (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
56.24%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
3.20%
*******
*******
*******
*******
Profit or Loss
*******
48.37%
*******
*******
*******
*******
Net Worth
*******
5.87%
*******
*******
*******
*******
EBITDA
*******
-68.59%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Coromandal Biotech Industries (India)?

In 2022, Coromandal Biotech Industries (India) had a promoter holding of 24.73% and a public holding of 75.27%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹26,000,000.00

Charges Breakdown by Lending Institutions
  • Bank Of Baroda : 2.60 Cr
Latest Charge Details
Date Lender Amount Status
01 Mar 1993 Bank Of Baroda ₹2.60 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Coromandal Biotech Industries (India)?

Unlock and access historical data on people associated with Coromandal Biotech Industries (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Coromandal Biotech Industries (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Coromandal Biotech Industries (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Coromandal Biotech Industries (India)
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Coromandal Biotech Industries (India) Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Director Appointment

    Duvvuru Suman Reddy was appointed as a Director was appointed as a Director on 09 Aug 2025 & has been associated with this company since 6 months 27 days . was recorded as a recent event.

  • Director Appointment

    Progress on Kaku Mahesh Reddy was appointed as a Director was appointed as a Director on 09 Aug 2025 & has been associated with this company since 6 months 27 days . was documented.

  • Balance Sheet

    Progress on Coromandal Biotech Industries (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada. was documented.

  • Director Appointment

    The activity Menakuru Seetharamireddy was appointed as a Director was appointed as a Director on 13 Feb 2019 & has been associated with this company since 7 years 21 days . was completed.

  • Director Appointment

    Progress on Devireddy Venkata Krishna Reddy was appointed as a Director was appointed as a Director on 29 Sep 2017 & has been associated with this company since 8 years 5 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Coromandal Biotech Industries (India) Limited?

The CIN of Coromandal Biotech Industries (India) Limited is U05005AP1992PLC013968.

Where is Coromandal Biotech Industries (India) Limited headquartered?

Coromandal Biotech Industries (India) Limited is headquartered at Sy No. 962Kothakodur (V) T P Gudur (M), Andhra Pradesh, Andhra Pradesh.

When was Coromandal Biotech Industries (India) Limited incorporated?

Coromandal Biotech Industries (India) Limited was incorporated on 12 March 1992.

Who are the current directors of Coromandal Biotech Industries (India) Limited?

The current directors of Coromandal Biotech Industries (India) Limited are

What is the primary industry of Coromandal Biotech Industries (India) Limited?

The primary industry of Coromandal Biotech Industries (India) Limited is Agriculture.

Is Coromandal Biotech Industries (India) Limited a listed company?

Coromandal Biotech Industries (India) Limited is unlisted.

What is the capital structure of Coromandal Biotech Industries (India) Limited?

The authorized capital of Coromandal Biotech Industries (India) Limited is ₹15.00 Cr, and the paid-up capital is ₹8.57 Cr.

What is the compliance status of Coromandal Biotech Industries (India) Limited?

The compliance status of Coromandal Biotech Industries (India) Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available